Skip to content
Mendelspod Podcast cover art

All episodes

Mendelspod Podcast, 582 episodes. Page 4 of 6.

#
Title
301

We Can See Tumor Heterogeneity. Now What? We Ask Cathy Smith, UCSF

302

Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara

303

'The Movement:' John Cumbers Previews the Rapidly Growing SynBioBeta 2019

304

Anya Prince on Our Current Vulnerability to Genetic Discrimination

305

Do Long Reads Hold Answers for Alzheimer’s? with Mark Ebbert, Mayo

306

With Nanopore Sensing Beyond Sequencing, Ontera Takes 'Lab' to the Field

307

Mark Chaisson on Two New Structural Variation Papers

308

Early Cancer Detection: Is This Company Ahead of Grail?

309

June 2019 Review with Nathan and Laura: Gene Patents, Grail, Dr. Lynch

310

Should Genomic Screening Be Standard of Care? with Adam Buchanan, Geisinger

311

May 2019 Review with Nathan and Laura: Gene Therapies, DTC Shifts, Gender and Sports

312

Toward the Human Pan Genome with Adam Phillippy, NHGRI

313

Laura Hercher on the DTC Genetic Testing Landscape

314

Arcadia Biosciences Pivots to Bring Us Non-GMO, High Fiber GoodWheat and Better Cannabis

315

April 2019 Review with Nathan and Laura: uBiome Raided by FBI, PRS for Obesity, and a Gene Therapy Cure

316

The Era of the Social Genome with Rodrigo Martinez, Veritas Genetics

317

Reassessing Alzheimer’s with Larry Goldstein, UCSD

318

Family Surprises Care of the Home DNA Test with Brianne Kirkpatrick

319

March 2019 with Nathan and Laura: Old Envelopes, Wooly Mammoth DNA, and the Night King

320

Single Cell Analysis Shows Important New Detail in Key Clinical Study of AML: Koichi Takahashi, MD Anderson

321

Science Communication in a Post Fact World with Erik Clausen

322

February 2019 Review with Nathan and Laura: Family Surprises, IQ Profiling, and Chinese Surveillance

323

Heretic No Longer? Meet Michael Joyner, Precision Medicine’s Critic-in-Chief

324

The Internet of Biology Revolution-For Real This Time, with Brett Goldsmith, Cardea

325

January 2019 Review with Nathan and Laura: Cloning, CRISPRing, DTC, and Paleogenomic Overreach

326

Cara O'Neill of the Cure Sanfilippo Foundation Tells Her Story

327

PregSource: The NIH’s Crowdsourcing Project for Pregnancy Data with Caroline Signore

328

Meet Christian, Janos, and the New World of 3D Oncology

329

Has Computational Modeling for Cancer Genomics "Arrived?" with Shirley Liu, Dana Farber

330

Amy Harmon of the NYT on Race & Genetics, Women in Science

331

CRISPR or Not, You Can't Genetically Enhance Humans, Says Sci-Fi Author Kim Stanley Robinson

332

The New World of Infectious Disease Diagnosis: Out in the Field with David Hong of Karius

333

California Life Science Industry Steps to New Heights - the 2019 Edition with Sara Radcliffe

334

Nathan and Laura on CRISPRed Babies and Other November 2018 Stories

335

Ellen Matloff on a New Digital Genetic Counseling Product for DTC Customers

336

Connecting the Dots for a Community of Rare Disease Patients: Terri Klein, MPS Society

337

Keith Robison and Shawn Baker on Illumina Buyout of PacBio

338

October 2018 Review with Nathan and Laura: ASHG Does Race, Parents Do Gene Therapy, Unsung Demons

339

A Point-of-Care CBC Test Based on a Few Drops of Blood—Is This the Real Thing? with Danny Levner, Sight Diagnostics

340

It’s a Gold Rush in Single Cell Genomics, Says Joachim Schultze, U of Bonn

341

A Market Solution for Biospecimen Quality Standards with Matt McLoughlin, Scientist.com

342

September 2018 with Nathan and Laura: Studying the Same Genes and the Matt Fender Story

343

Single Cell Sequencing Tailor Made for Nephrology, Says Vivek Bhalla, Stanford

344

It’s the Social Factors, Stupid! Lisa Suennen on Healthcare, Her Career, Digital Health Investing, and . . . Just Being Herself

345

Concerned About DTC Test Quality? Ask Two Questions, Says Daryl Pritchard, PMC

346

August 2018 Review with Nathan and Laura: The polygenic month

347

An International Perspective on How to Improve Biobanking with Kirstin Goldring

348

A Seqster Preview with Founder Ardy Arianpour

349

Detective Stories from the Genomic War Room with Ramesh Hariharan

350

Should Biobanking Come Under CLIA? Shannon McCall, Duke

351

Pharma Stepping Up, Footing the Bill for Genetic Testing & Counseling: Jordanna Mora, Alnylam

352

Are We Asking Too Much of Genomics in Cancer Research? Tony Letai, Dana Farber

353

I Won’t Rest Until We Have Quality Standards in Place for Biospecimens: Carolyn Compton, ASU

354

May 2018 with Nathan and Laura: The Free Exome, California Database, and Mosaicism

355

Has Diagnostic Testing Plateaued? Alka Chaubey, Greenwood Genetic Center

356

A New Way for DTC? Nathan Pearson, Root Deep Insight

357

Genetic Testing in the Age of Trump: Hank Greely, Stanford

358

Genetic Testing is Dead, Long Live Genetic Testing: Sean George of Invitae

359

April 2018 with Nathan and Laura: Golden State Killer and the Cancer Prediction Space

360

Liquid Biopsy for Infectious Disease with Mickey Kertesz, Karius

361

Nanopore Sequencing and the Future of Cancer Research with Chia-Lin Wei, JAX

362

A New Method for Long Reads: Hanlee Ji of Stanford on Cancer Genomics Tech 2018

363

March 2018 in Genomics with Nathan & Laura: DTC BRCA and Revisiting All of Us

364

With More Tools in the Box, Lon Cardon Says We’re in a New Age of Drug Development

365

Personalized Medicine in the Trump Era with Edward Abrahams

366

Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel

367

February 2018 in Genomics with Nathan & Laura: 23andMe Goes for the Gold, Trump Year One

368

State of Sequencing 2018 with Keith Robison, Omics! Omics! Blogger

369

Direct RNA-Seq Project Shows Nanopore Sequencing Can Reveal New Insights into Basic Biology: Winston Timp, JHU

370

January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test

371

Going Beyond the Liver with RNAi: Chris Anzalone of Arrowhead Pharma

372

Vice Chancellor Keith Yamamoto on UCSF’s Role in Medicine Today

373

The Global Business of Reproductive Genetic Testing with Gary Harton, Igenomix

374

The State of Genomics 2018 with Nathan, Laura, and Misha

375

Sharon Begley of STAT News

376

A New “Middle Way” for Genomics, with Physical Chemist, Yuval Ebenstein

377

Sara Demy on Biotech CEOs

378

November 2017 with Nathan and Laura: The Stem Cell Story We’ve All Been Waiting For and a Sea Change for DTC Testing

379

Seattle Startup Takes Precision Oncology to the Next Step: Carla Grandori, CEO, SEngine

380

Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur

381

Huh? 30 Million Americans Have a Rare Disease? Howard Jacob on the State of Clinical Sequencing

382

With their Own Manufacturing Facility, Seattle Children’s Goes Big into CAR-T, Rare Disease

383

With Immuno Oncology Comes a New Focus on Rare Cells

384

We've Become Too Single Variant Centric, Says Deanna Church on Genome Analysis

385

Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai

386

September 2017 with Nathan and Laura: Venter Blunder, RNAi Returns, and Monthly Science Moments

387

Charting the Dark Matter of Cancer Genomes with Jim Broach

388

Why Childhood Cancers Need Their Own Gene Panel: Tim Triche

389

Exploring the Exome and the Future of Genomics with Jay Shendure

390

August 2017 Review with Nathan and Laura: CAR-T Cashes In, Embryos Edited in US, and the Invitae Incident

391

The First In-Human Gene Editing Trial in the U.S. - And It’s Not with CRISPR

392

Thermo, Pfizer, and Novartis Pull Off a First for NGS in Lung Cancer

393

Making Genetic Testing Mainstream Medicine with Sean George, Invitae

394

Need Better Standards for Your Clinical Assays? NIST Can Help

395

Turning on Your DNA with Justin Kao, Helix

396

Will This New Nano Technology Be the Microarray of Genomic Structural Variation? Barrett Bready, Nabsys

397

George Church on What Comes After CRISPR

398

Is CRISPR Controversy Science or Spin? June 2017 Review with Nathan and Laura

399

We Need a Google Maps for Metagenomics, Says Rob Knight, UCSD

400

Move Over PDL1: New Test Combo Adds RNAseq to Better Track Immune Escape